Between one war here and another there, and an economic situation that leaves no one feeling secure, the plan to cut humanitarian aid implemented at the start of his term by United States President Donald Trump has already fallen into oblivion. Yet, while international attention shifts elsewhere, the consequences continue to accumulate silently, among full warehouses, expiring medicines, and suspended decisions that end up turning into recurring costs and dangerous consequences for health – especially women’s – globally.
THE COST OF INACTION
It is in this scenario that the most recent case emerges, reported by Reuters, according to which the United States is paying nearly $25,000 a month to store contraceptives purchased for family planning programs in the poorest countries in Belgium, now largely unusable. These are stocks worth approximately $9.7 million, stuck since foreign aid was frozen, and which should have reached clinics and health programs in Africa and other low-income areas. Meanwhile, the cost of their management and transport has already exceeded $360,000 in just over a year, while their usefulness has progressively dissolved in administrative deadlock.
THE WASTE OF SUPPLIES
The initial aid freeze had immediate effects, but the deterioration of stocks occurred in the following months, when part of the contraceptives was moved without adequate storage conditions. According to a report from the former USAID Inspector General’s Office, about $8 million worth of materials became unusable after the transfer, while only a residual fraction was still potentially usable before further delays and lack of decisions on distribution. In parallel, an internal memorandum cited last March by the New York Times described a situation in which up to $8.1 million worth of contraceptives were already compromised due to unrefrigerated storage and interrupted logistics.
REVOKED DECISIONS AND INSTITUTIONAL DEADLOCK
Over time, operational choices have followed one another without stability. Initially, the transfer and even disposal of stocks were ordered, then partially suspended and finally revoked. In this alternation of directives, supplies remained suspended between warehouses and transit sites, without a defined final destination. The internal document cited by the Nyt also highlighted proposals for donation to humanitarian organizations such as Médecins Sans Frontières.
However, these hypotheses were not pursued also due to fear that the choice could generate strong media attention and become the subject of political controversy in the United States. In particular, a possible donation abroad risked being interpreted as a controversial ideological decision, reigniting the internal debate on funding contraception in international aid programs and attracting criticism from sectors opposed to this type of assistance.
In this context, political caution and reputational risk contributed to blocking operational decisions, leaving supplies in a prolonged suspended condition.
A HALTED AID SYSTEM AND CLINICS WITHOUT SUPPLIES
The picture fits into a broader reduction of U.S. commitment to family planning programs, described by several analyses as one of the most radical changes of recent decades. In several African and Asian countries, health organizations have reported the closure of thousands of clinics and a growing shortage of essential contraceptives, from pills to intrauterine devices. According to data released by the International Planned Parenthood Federation, over 1,300 service points have been closed and millions of people have lost access to reproductive health services.
THE PRICE WOMEN PAY
The reduction in U.S. funding has not only affected supplies but has directly impacted women’s concrete ability to access family planning services. In many rural and peripheral areas, where programs funded by foreign aid often represented the only available health network, clinic closures have meant the immediate disappearance of contraceptive distribution points and counseling services.
For many women, this translates into a loss of autonomy over reproductive choices: no longer being able to access the pill or intrauterine devices means facing unplanned pregnancies without prevention tools, or resorting to less safe or uncontrolled methods by the health system. In some contexts, the absence of healthcare personnel and the reduction of community visits also make it difficult to obtain reliable information or continuous assistance.
The consequences are amplified where services were integrated with other forms of assistance, such as maternal health, HIV prevention, or post-violence support: the closure of facilities interrupts multiple levels of care simultaneously. In this void, women with fewer economic resources or living far from urban centers are the most exposed, as they have no private alternatives nor the possibility to easily travel to access remaining active services.
A POLICY OF CUTS
The decisions fit into a broader strategy of reducing international aid. According to various analyses cited in global health reports, the United States represented about 40% of global funding for contraception until 2024, supporting programs that reached tens of millions of women. The progressive withdrawal of these funds coincided with the closure or downsizing of hundreds of health projects and with a reallocation of resources towards sectors considered priorities such as HIV, malaria, and tuberculosis, leaving many prevention and family planning services uncovered.
In this context, the cost of contraceptives stuck in Europe and their management becomes only a visible part of a larger system, where political and logistical decisions intertwine with public budgets, recurring expenses, and interrupted health services in dozens of low-income countries.
